T
TSHA//CIK 0001806310
Taysha Gene Therapies, Inc.
Market Data
$5.60−$0.18 (−3.11%)
TSHA · Last trade
Prev Close
$5.78
Range (31d)
$5.60 – $6.68
Recent Filings
- SCHEDULE 13G/A15.6 KBTaysha Gene Therapies, Inc.Aug 14, 4:47 PM ET·0001231919-26-000928
- SCHEDULE 13G/A12.0 KBTaysha Gene Therapies, Inc.Aug 13, 5:38 PM ET·0000895421-26-000269
- 10-Q15.4 MBTaysha Gene Therapies, Inc.Aug 11, 4:07 PM ET·0001193125-26-344610
- 8-K242.3 KBTaysha Gene Therapies, Inc.Aug 11, 4:05 PM ET·0001193125-26-344594
- 8-K541.9 KBTaysha Gene Therapies, Inc.Jun 25, 4:26 PM ET·0001193125-26-282855
- 8-K4.5 MBTaysha Gene Therapies, Inc.Jun 22, 8:14 AM ET·0001193125-26-276738
- 8-K152.7 KBTaysha Gene Therapies, Inc.Jun 2, 4:05 PM ET·0001193125-26-253478
- 10-Q9.7 MBTaysha Gene Therapies, Inc.May 6, 8:30 AM ET·0001193125-26-207666
- 8-K224.6 KBTaysha Gene Therapies, Inc.May 6, 8:11 AM ET·0001193125-26-207633
- 10-K19.9 MBTaysha Gene Therapies, Inc.Mar 19, 8:31 AM ET·0001193125-26-115202
Insiders
10- Alam KamranCHIEF FINANCIAL OFFICER
- Astellas Pharma Inc.10% Owner
- Audentes Therapeutics, Inc.10% Owner
- Donenberg Phillip B.Director
- Long Alison SDirector
- Manning Paul B10% Owner
- Nagendran SukumarDirector, President and Head of R&D
- Nolan Sean P.Director, Chief Executive Officer
- PRASAD SUYASHCMO and Head of R&D
- Reape KathleenDirector
Tickers
Addresses
business
3000 PEGASUS PARK DRIVE SUITE 1430
DALLAS, TX, 75247
mailing
3000 PEGASUS PARK DRIVE SUITE 1430
DALLAS, TX, 75247